HGH Fragment 176-191 Clinical Studies
This 2004 HGH Fragment 176-191 Study (also known as AOD9604) indicates that the peptide was highly successful at stimulating the metabolism of body fat in humans and is the first drug to ever do so – all other weight loss drugs (such as Sibutramine) contribute to loss of body weight indirectly by reducing appetite and not actually burning fat itself.
The study was conducted over 3 months at 6 different doses with one of the most interesting conclusions being that the lowest daily dose of 1mg (1000mcg) was found to be the most effective. Since the 1mg dose was taken orally, it would be the equivalent of approximately 250mcg (0.25mg) by injection. The average overall weight loss in 3 months was 3kg of fat, 300% more than for those test subjects not taking the peptide.
Additionally, unlike normal HGH injections which have negative effects on blood glucose, HGH Fragment 176-191 did not negatively effect glucose tolerance, but rather improved it and also improved cholesterol levels.
Side Effects of HGH Fragment
Quite amazingly both clinical trials, and feedback from the thousands of people who experiment with HGH Fragment 176-191 for fat/weight loss, have resulted in no side effects being reported. Since the peptide has been used in medical circles for almost 10 years now, it’s long-term safety is very well established and it can be considered a safe, cheap and effective alternative to actual HGH injections and other weight loss drugs such as Phentermine (Duromine, Adipex) which it was shown to outperform.